Ryboquin ryboquin.co.uk


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

Ryboquin, a drug development company, is focused on commercializing patented technologies in the area of human cancer medicine. The Company's aim is to grow shareholder value by developing new, effective oncology therapies for which there is significant demand from patients and healthcare professionals around the world.

Ryboquin, a drug development company, is focused on commercializing patented technologies in the area of human cancer medicine. The Company's aim is to grow shareholder value by developing new, effective oncology therapies for which there is signific...Show all

Company (Alive / Active)

Phone: +44 (0) 844 822 7027

Fax:

Ettrick Riverside
Dunsdale Road
Selkirk, TD7 5EB
Scotland, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ryboquin $4.6M Jul 4, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ryboquin Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Modulators of itch ubiquitinase activity Apr 23, 2015 May 23, 2017 Patent
Modulators of itch ubiquitinase activity Jan 19, 2006 Jun 09, 2015 Patent